Altisource Asset Management Corporation ("AAMC" or the "Company") (NYSE American: AAMC) posts the attached progress reports for January, February and March 2024 concerning Project Alpha, Phase II, ...
New deals and drug launches to offset Keytruda’s patent expiration. All in all, Merck showed it is making substantial progress in preparing for 2028’s patent expiration of its blockbuster drug, ...
For the first quarter as Novonesis, the company delivers 4% organic sales growth in line with expectations. Novonesis maintains the 2024 outlook of 5-7% organic sales growth with an adjusted EBITDA ...
Some results have been hidden because they may be inaccessible to you